Reston, Virginia – July 25, 2018 - Clinical Care Options (CCO) has been selected to serve as the CME conference coverage provider of the 2019 Crohn’s & Colitis Congress. The Crohn’s & Colitis Congress, a partnership between the Crohn’s & Colitis Foundation (the Foundation) and the American Gastroenterological Association (AGA), is the premier conference for inflammatory bowel disease (IBD) professionals. By building on our expertise in developing educational programming focused on immune-mediated disease, CCO will create a conference coverage program that will impact thousands of clinicians who manage patients with IBD.
CCO’s educational coverage of the congress, which will be held February 7-9, 2019, in Las Vegas, Nevada, will focus on the most cutting-edge advances in both clinical practice and research in IBD, and will include an analysis of highlights from both the clinical and research sessions presented during the two-day congress. Learners will have access to live and on-demand CME-certified Webcasts and downloadable presenter slides, for use as self-study resources or in their own presentations.
Participants will be provided with different perspectives, hear about potential treatments on the horizon, and take away practical information that can immediately be implemented in practice.
“IBD is at an exciting time of discovery and new therapeutic approaches. The Crohn’s & Colitis Congress is a unique meeting that brings together leading scientists and clinicians to discuss these advances,” said Maria T. Abreu, MD, AGAF, organizing committee co-chair for the Crohn’s & Colitis Congress. “The AGA and the Foundation are excited to work with CCO to bring the high-quality content presented in Las Vegas to the entire community of IBD healthcare providers, which will lead to better outcomes for all patients with IBD.”
“The 2019 Crohn’s & Colitis Congress is a necessary asset for the IBD healthcare provider community,” said Alyce Kuklinski, General Manager, Virology & Internal Medicine, CCO. “We are honored to be partnering with both the AGA and the Foundation and look forward to providing timely and relevant coverage of this important conference.”
About the Crohn’s and Colitis Foundation
The Crohn’s & Colitis Foundation is the largest non-profit, voluntary health organization dedicated to finding cures for IBD. The Foundation’s mission is to cure Crohn’s disease and ulcerative colitis, and to improve the quality of life of children and adults who are affected by these diseases. The Foundation works to fulfill its mission by funding research; providing educational resources for patients and their families, medical professionals, and the public; and furnishing supportive services for those with IBD. For more information, visit http://www.crohnscolitisfoundation.org/, call 888-694-8872, or email email@example.com.
About the American Gastroenterological Association
The AGA is the trusted voice of the gastroenterological community. Founded in 1897, the AGA has grown to more than 16,000 members from around the globe who are involved in all aspects of the science, practice, and advancement of gastroenterology. The AGA Institute administers the practice, research, and educational programs of the organization. For more information, visit www.gastro.org.
About Clinical Care OptionsClinical Care Options, LLC, is a global leader in the development of innovative educational programs and technology platforms. CCO’s team has been a pioneer in the creation of continuing education and decision support resources for healthcare professionals both in the United States and around the world for more than 2 decades. For more information, visit clinicaloptions.com.